Michael P. Wallace

Michael P. Wallace has extensive work experience in the medical industry. In 2022, they became a Board Member for Venova Medical and the CEO & Founder of 880 Medical LLC. Michael P. also became a Venture Partner for ShangBay Capital. In 2021, they became the Co-Founder and Board Member for Early Bird Medical, Inc., a women health company. In 2018, they became the CEO & Co-Founder of Devoro Medical Inc, a peripheral vascular device company. In 2017, they became the CEO & Founder of 880 Medical LLC, where they developed a novel stroke (AIS) thrombectomy solution. In 2014, they became the Chief Technical Officer and VP Operations for Silk Road Medical, Inc., a company that eliminates the risk of pre-operative strokes associated with carotid vascular disease interventions. In 2009, they became the Co-Founder of CardioProlific Inc, which was acquired by Philips Healthcare in 2017. In 2011, they became the President & Co-Founder of TW Medical LLC, which was acquired by Stryker Neurovascular in 2015. Finally, in 2013, they became the VP of R&D for Boston Scientific's Electrophysiology Division, where they led a bi-coastal R&D organization.

Michael P. Wallace received their Bachelor of Science in Mechanical Engineering from the University of Delaware in 1991, and their Master of Science in Mechanical Engineering with a Bioengineering Emphasis from the University of California, Davis in 1995.